Galantamine is effective in treating mild to moderate Alzheimer’s disease, improving cognition, functionality and neuropsychiatric symptoms. Its dual mechanism (acetylcholinesterase inhibition + nicotinic modulation) provides additional benefits over other acetylcholinesterase inhibitors. This evidence concerns the gene ACHE and Alzheimer disease.